Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...

Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that ...

Alcon shares fell after the Swiss eye-care giant trimmed its full-year guidance due to President Trump’s trade tariffs.

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on ...

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...

Global eye care leader Alcon has announced it will acquire Lake Forest-based Staar Surgical, a manufacturer of implantable ...

Shares of Alcon fell after the company posted a lower second-quarter profit and cut its full-year sales outlook, saying it expected a full-year tariff impact of $100 million. The stock was down 9.1% ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the ...

The company forecasts a full-year gross tariff impact of around $100 million, up from $80 million expected previously ...

Alcon ALC during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing ...